Biomea Fusion Inc (NAS:BMEA)

$ 4.23 -0.12 (-2.76%) Market Cap: 152.05 Mil Enterprise Value: 18.22 Mil PE Ratio: 0 PB Ratio: 1.12 GF Score: 40/100

Biomea Fusion Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Biomea Fusion Inc ADA Scientific Sessions Discussion Transcript
Jun 27, 2023
Biomea Fusion Inc to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes- Conference Call Transcript
Mar 28, 2023
Biomea Fusion Inc to Discuss FDA Clearance of IND for BMF-219 in Type 2 Diabetes Transcript
Dec 15, 2022
Biomea Fusion Inc Covalent Menin Inhibitor BMF-219's Activity in Diabetes as Presented at the 82nd American Diabetes Association Annual Conference Transcript
Jun 06, 2022

Biomea Fusion Inc ADA Scientific Sessions Discussion Transcript

Jun 27, 2023 / 12:30AM GMT

Release Date Price: $21.85 (-10.51%)

Transcript

Operator

Good morning ladies and gentlemen, thank you for standing by, and welcome to Investor Conference Call and Webcast to discuss Biomea Fusion ADA Scientific Sessions presentation from San Diego. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. (Operator Instructions) Please note that today's conference is being recorded.

I will now hand the conference over to your speaker host, Mr. Ramses Erdtmann, please go ahead, sir.

Ramses Erdtmann

Biomea Fusion - COO, President and Co-Founder

Yes. Thank you, Lyvia. Good morning everyone, and thank you for dialing in at this early hour. We're very excited to discuss with you this morning the press release we issued this past Friday evening, announcing data we presented at the American Diabetes Association's Scientific Sessions here in San Diego.

Some quick introductions from my side. My name is Ramses Erdtmann, I'm COO, President and Co-founder of Biomea. With me on the call today from our team and available to answer

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.